Antech Diagnostics
Antech Diagnostics is a privately held US veterinary diagnostics company and subsidiary of Mars, Incorporated, operating North America's largest veterinary reference lab network. It serves veterinary practices with reference lab testing, in-house analyzers, Sound imaging equipment, AI radiology interpretation, and specialist consultation.
- Company typePrivate
- Founded1994
- HeadquartersIrvine, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingServices
What Antech Diagnostics does
Antech Diagnostics, Inc. is a US-based veterinary diagnostics company and wholly-owned subsidiary of Mars, Incorporated, operating within Mars Petcare's Science & Diagnostics division. The company is positioned as North America's largest veterinary reference laboratory network and serves veterinary practices across the United States, Canada, the United Kingdom, and additional European markets. Its offering is a fully integrated diagnostic ecosystem combining reference laboratory send-out testing, in-house bench-top and handheld analyzers (Element series, trūRapid, Eurolyser Cube, scil Vet abc Plus+), Sound-branded imaging equipment (ultrasound, digital radiography, CT, C-Arm, laser therapy), AI-powered radiology interpretation (RapidRead, RapidRead Dental), proprietary specialty tests (KeyScreen GI Parasite PCR, CADET BRAF, Nu.Q, Allercept, FIRSTract), and access to 130+ board-certified pathologists and 50+ specialists for consultation.
The business operates across multiple revenue streams: recurring reference lab per-test fees (with completion and recheck codes), hardware sales plus consumables for in-house analyzers, imaging equipment sales and service subscriptions, and Allercept custom immunotherapy formulations. Distribution is direct-to-practice via dedicated phone support, account managers, and the HealthTracks cloud platform for ordering, results, and patient data management. Product innovation is concentrated in AI-enabled imaging interpretation and proprietary molecular diagnostics, with sustained launch cadence through 2025 and into 2026.
The company is privately held and does not disclose revenue. Its strategic trajectory has been defined by a series of parent-funded acquisitions — EUROLyser (2022), Heska Corporation at approximately $1.3 billion (2023), SYNLAB.vet GmbH (2023), and Cerba HealthCare (2025) — alongside geographic expansion into the UK and Europe, positioning Mars Science & Diagnostics as a global consolidator in veterinary laboratory services and in-clinic diagnostics.
Antech Diagnostics firmographics
Firmographics- Name
- Antech Diagnostics
- Legal name
- Antech Diagnostics, Inc
- Website
- https://antechdiagnostics.com
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Antech Diagnostics is a privately held US veterinary diagnostics company and subsidiary of Mars, Incorporated, operating North America's largest veterinary reference lab network. It serves veterinary practices with reference lab testing, in-house analyzers, Sound imaging equipment, AI radiology interpretation, and specialist consultation.
- Ownership category
- akta.pro rank
Antech Diagnostics industry classification
Industry- Product category
- Veterinary Diagnostic Laboratory Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Veterinary Services (54194), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Services-Medical Laboratories (8071), Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Reference Laboratory Testing (Clinical Pathology & Chemistry) (HLAMADAA)
- akta.pro secondary industries
- Point-of-Care & In-Clinic Diagnostics (Rapid Tests, Benchtop Analyzers) (HLAMADAI), Veterinary Anatomic Pathology (Histopathology & Cytology) (HLAMADAB), Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology) (HLAMADAC), Imaging/Lab Integration & Results Management (PACS, LIS Connectivity, Reporting) (HLAMAGAK)
Keywords
Where Antech Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Irvine
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Antech Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Reference Laboratory Testing Services: Send-out diagnostic testing services to veterinary practices across North America. Provides comprehensive testing including chemistry, hematology, pathology, microbiology, molecular diagnostics, and specialized panels. Revenue generated through per-test fees with completion codes and recheck codes at reduced pricing for ongoing patient monitoring.
- In-House Diagnostic Equipment Sales: Sale of bench-top and handheld analyzers including Element series (DCX, HT5+, HT5, i+, POC), HeskaView telecytology systems, trūRapid rapid tests, and related consumables. Equipment sold to veterinary clinics for in-practice testing with ongoing consumable revenue.
- Imaging Equipment and Services: Sale and service of diagnostic imaging equipment including digital radiography, ultrasound, CT, and therapeutic lasers through Sound brand. Additionally provides teleradiology and RapidRead AI interpretation services as ongoing subscription.
- Allercept Immunotherapy Products: Custom immunotherapy treatments (shots and drops) manufactured based on individual patient allergy testing results. Revenue from allergen-specific immunotherapy formulations for dogs, cats, and horses.
Go-to-market motion2 records
Distribution channels5 records
Marketing channels5 records
Antech Diagnostics product offering
Product offeringCore offering
Antech Diagnostics operates North America's largest veterinary reference laboratory network, providing send-out diagnostic testing across chemistry, hematology, pathology, microbiology, molecular diagnostics, cancer screening, and allergy panels. The company complements this with a portfolio of in-clinic diagnostic analyzers and rapid tests (Element series, trūRapid series, Eurolyser Cube), AI-powered imaging interpretation (RapidRead and RapidRead Dental), Sound-branded imaging equipment, board-certified specialist consultation across nine disciplines, and the HealthTracks cloud platform for test ordering and results delivery.
Differentiator
Problem solved
Functional benefit
Brands
- RapidRead™: AI-powered radiology interpretation tool for veterinary radiographs, including tooth-by-tooth dental analysis.
- PennHIP™
- Element™ Series
- KeyScreen™
- Accuplex™
- Allercept™
- CADET™ BRAF
- Nu.Q®
- trūRapid™
- HealthTracks™
- HeskaView™
- Loved for Life by Antech™
- Eurolyser Cube™
- scil Vet abc Plus+
Products and services
- Reference Laboratory Testing Services North America's largest veterinary reference laboratory network providing send-out diagnostic testing including chemistry, hematology, pathology, microbiology, molecular diagnostics, and specialized panels to veterinary practices with 24-48 hour turnaround for most tests.
- KeyScreen GI Parasite PCR Cutting-edge gastrointestinal parasite PCR test using proprietary technology to identify parasite genetic material in fecal samples from dogs and cats, detecting 20 intestinal parasites, benzimidazole resistance in hookworms, and zoonotic potential of Giardia.
- Accuplex Multiplexed canine vector-borne disease screening test detecting heartworm antigen and antibodies for tick-borne diseases, with results typically available by 8:00 am the next day.
- Canine Cancer Diagnostics (CADET BRAF and Nu.Q) Reference laboratory cancer screening tests including CADET BRAF mutation detection for early canine bladder/prostate cancer (TCC/UC) and Nu.Q measurement of plasma nucleosome concentration for lymphoma and hemangiosarcoma detection.
- Allercept Allergy Testing and Immunotherapy Serum allergy testing using patented IgE detection technology sensitive to 10 picograms, combined with custom immunotherapy treatments (shots and drops) manufactured for individual patients with 50-80% positive response rates reported.
- Element Series In-House Diagnostic Analyzers Bench-top and handheld in-clinic diagnostic analyzers including Element i+, DCX, HT5+, HT5, DC5X, AIM, COAG+, and POC for chemistry, hematology, blood gas, and coagulation testing, plus Element i+ SDMA testing for kidney function assessment added in January 2026.
- trūRapid In-House Test Series Rapid in-clinic immunodiagnostic tests including trūRapid FOUR for heartworm antigen, Lyme C6 antibody, Anaplasma, and Ehrlichia; plus Heartworm, HW/Lyme, and FIV/FeLV tests with room temperature storage and no refrigeration required.
- Sound Imaging Equipment Diagnostic imaging equipment line sold under the Sound brand including digital radiography, ultrasound, CT, C-arm, and therapeutic laser systems for veterinary practices, with installation, training, and demo support.
- RapidRead AI Radiology Interpretation AI-powered radiology interpretation service combining computer vision analysis with board-certified veterinary radiologist overread for enhanced diagnostic confidence on general radiographs.
- RapidRead Dental AI-powered computer vision tool delivering tooth-by-tooth analysis of veterinary intraoral dental radiographs in approximately 10 minutes, with a feline-specific version launched January 2026 addressing small tooth size and high tooth resorption prevalence.
- PennHIP Hip joint laxity measurement service used to estimate risk of canine osteoarthritis, with online training and a locator service for PennHIP-certified veterinarians.
- HeskaView Telecytology Telecytology service providing digital cytology consultations and practice information management system (PIMS) software solutions for veterinary practices.
- HealthTracks Platform Cloud-based platform for ordering diagnostic tests, accessing laboratory and imaging results, and managing patient data, available via web and mobile with self-service onboarding for veterinary practices.
- Consultation Services Peer-to-peer expert medical consultation services from 50+ board-certified specialists across nine disciplines, providing veterinary practices with specialist support on complex cases.
- Loved for Life by Antech Preventive care wellness program offering comprehensive diagnostic profiles designed to support lifelong pet health monitoring.
Quantifiable outcome
- 98% overall agreement with reference lab methods for trūRapid FOUR vector-borne disease screening
- +4 more outcomes
Companies that use Antech Diagnostics
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Antech Diagnostics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature10 records
Antech Diagnostics partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered minor and core.
- Vet Set GominorAntech launched the Antech Veterinary Futures Scholarship in partnership with Vet Set Go to support aspiring veterinary professionals. The scholarship invests in students to ensure pets receive quality care, coinciding with World Veterinary Day 2026.
- Cerba HealthCarecoreMars acquisitions of Cerba HealthCare to consolidate presence in clinical pathology markets as part of Mars Science & Diagnostics expansion.
- SYNLAB.vet GmbHcoreMars Incorporated acquired Germany-based SYNLAB.vet GmbH to strengthen its position in the European veterinary laboratory market and expand global diagnostics offerings.
- Heska CorporationcoreMars, Incorporated acquired Heska Corporation for approximately $1.3 billion to expand its pet health diagnostics capabilities. Heska specializes in advanced veterinary diagnostics including Element series analyzers, Nu.Q cancer screening, and telecytology solutions now integrated into Antech's portfolio.
- EUROLysercoreARCHIMED's MED II fund sold point-of-care diagnostics company EUROLyser to Antech Diagnostics, a subsidiary of Mars Veterinary Health. EUROLyser specialized in point-of-care diagnostic equipment including the Eurolyser Cube platform now offered under Antech's in-house diagnostics portfolio.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Antech Diagnostics competitors and assessment
Company assessmentEmerging players
- PetDx: PetDx offers OncoK9 liquid biopsy test for canine cancer detection using next-generation sequencing, directly competing with Antech's Nu.Q cancer screening platform in the emerging veterinary oncology diagnostics category.
- Basepaws (Zoetis): Basepaws, acquired by Zoetis, offers feline and canine genetic and oral microbiome testing; competes in the broader pet health diagnostics space with Antech's advanced molecular and screening panels, particularly for preventive care programs.
- Embark Veterinary: Embark offers direct-to-consumer and veterinarian-channel canine genetic testing and breed identification, an adjacent but distinct category from Antech's clinical pathology focus; both compete for veterinary practice attention and shelf space for advanced testing services.
Broad incumbents
- Virbac: Virbac is a global animal health company offering veterinary diagnostics (including allergy and infectious disease testing) as part of a broader pharmaceutical and nutrition portfolio, competing in select segments like allergy testing against Allercept.
- Zoetis: Zoetis is the largest animal health company globally and competes via its Vetscan in-house diagnostic suite (chemistry, hematology, urinalysis) and reference lab offerings through Vetscan Imagyst AI; broader portfolio includes pharmaceuticals and vaccines beyond diagnostics.
Regional players
- SYNLAB: SYNLAB is Europe's largest medical diagnostic services provider with veterinary diagnostics (SYNLAB.vet) now acquired by Mars; competes in European reference lab testing with similar clinical pathology and microbiology offerings to Antech in that geography.
- Cerba HealthCare: Cerba HealthCare is a European clinical pathology and specialty diagnostics provider also acquired by Mars in 2025; competes with Antech's European operations in clinical pathology and reference laboratory services across France, Belgium, Italy, and other European markets.
Others
- Volition Veterinary: Volition is the inventor and licensor of the Nu.Q nucleosome-based cancer screening technology used in Antech's canine cancer diagnostics; functions as a technology/IP partner rather than direct competitor, though Volition is commercializing competing veterinary cancer screening tests in some markets.
Direct peers
- IDEXX Laboratories: IDEXX is the dominant scaled competitor in veterinary reference laboratory services and in-house diagnostic analyzers (VetLab, Catalyst, ProCyte, SediVue), directly competing with Antech across chemistry, hematology, infectious disease, and reference lab send-out services in North America.
- Heska Corporation: Heska was a direct competitor in in-house veterinary diagnostic analyzers and allergy testing before being acquired by Mars in 2023 and integrated into Antech; products (Element series, Nu.Q, HeskaView) now operate within the Antech portfolio but historically competed head-to-head.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
Antech Diagnostics social profiles
Digital presenceAntech Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Antech Diagnostics leadership team
Management profileNumber of profiles
Profiles8 records
Antech Diagnostics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Antech Diagnostics M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Antech Diagnostics
What does Antech Diagnostics do?
Antech Diagnostics operates North America's largest veterinary reference laboratory network, providing send-out diagnostic testing across chemistry, hematology, pathology, microbiology, molecular diagnostics, cancer screening, and allergy panels. The company complements this with a portfolio of in-clinic diagnostic analyzers and rapid tests (Element series, trūRapid series, Eurolyser Cube), AI-powered imaging interpretation (RapidRead and RapidRead Dental), Sound-branded imaging equipment, board-certified specialist consultation across nine disciplines, and the HealthTracks cloud platform for test ordering and results delivery.
Is Antech Diagnostics a public or private company?
Antech Diagnostics is a private company. It is classified as corporate owned and is currently operating.
When was Antech Diagnostics founded?
Antech Diagnostics was founded in 1994. It employs 1,001 to 5,000 people.
Where is Antech Diagnostics based?
Antech Diagnostics is headquartered in Irvine, United States, in the North America region.
How does Antech Diagnostics make money?
Four revenue lines are on record. Reference Laboratory Testing Services are the primary driver. The others are in-House Diagnostic Equipment Sales, imaging Equipment and Services and allercept Immunotherapy Products.
Who are Antech Diagnostics's main competitors?
Emerging players on record are PetDx, Basepaws (Zoetis) and Embark Veterinary. Broad incumbents are Virbac and Zoetis. Regional players are SYNLAB and Cerba HealthCare. Volition Veterinary is listed as an others. Direct peers are IDEXX Laboratories and Heska Corporation.
Does Antech Diagnostics have an API?
No public API is recorded for Antech Diagnostics.
What industry is Antech Diagnostics in?
Antech Diagnostics's product category is Veterinary Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAMADAA, Reference Laboratory Testing (Clinical Pathology & Chemistry), with a secondary code of HLAMADAI, Point-of-Care & In-Clinic Diagnostics (Rapid Tests, Benchtop Analyzers). Its NAICS code is 621511 and its SIC code is 8071.